Dupilumab Reduces COPD Exacerbations
WASHINGTON -- Among chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation at high risk…
Browsing Tag
Exacerbations
Dupixent® (dupilumab) Demonstrates Potential to Become First Biologic to Treat COPD…
<!-- Name:DistributionId Value:8793979 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Vitamin D Supplements Do Not Reduce Asthma Exacerbations Overall
Elana Gotkine
MONDAY, Nov. 21, 2022 (HealthDay News) -- Vitamin D supplementation does not reduce the risk for asthma exacerbation in children overall,…
Fluticasone Delivery System Reduced Exacerbations of Chronic Rhinosinusitis
WASHINGTON -- Use of an exhalation delivery system with fluticasone (EDS-FLU; Xhance) significantly reduced acute exacerbations…
Optinose Announces Late Breaking Abstract Podium Presentation at IDWeek 2022
Presentation highlights a greater than 60% reduction in acute exacerbations and need for antibiotics for chronic sinusitis patients who used XHANCE in landmark ReOpen phase 3 clinical trial…
Are Antibiotics Needed for Moderate Acute Exacerbations of COPD?
BARCELONA -- The need for antibiotics in patients with chronic obstructive pulmonary disease (COPD) seeking treatment for moderate…
Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for…
XHANCE is the first and only nasal medication ever shown in Phase 3 controlled trialsto reduce exacerbations for patients with chronic sinusitis Pre-planned analysis of pooled data from…
Patient-Centered Intervention May Improve Severe Asthma Exacerbations
In a novel approach, researchers collaborated with patients to design and implement the trial.
A new approach to managing moderate-to-severe asthma has gained interest and attention and…
Akari Advances Lung Program with Inhaled Nomacopan Focused on Early Treatment of…
NEW YORK and LONDON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan…
A new clinical framework redefines the diagnosis of COPD Exacerbations
The recommendations of an international expert panel to update the definition and severity classification of chronic obstructive pulmonary disease (COPD) exacerbations will be presented by…